Tag: Long-acting beta-adrenoceptor agonist

Tag Visualization: Top 50 related tags by occurrence

Recent Related Articles to Long-acting beta-adrenoceptor agonist

TOP NEWS: AstraZeneca's Tezpire approved in EU for severe asthma - Morningstar

Added to Collection on: 2022-09-21 09:14:49

Tags for this article:

Health
Pharmaceutical industry
Respiratory therapy
Asthma
Corticosteroid
AstraZeneca
Medication
Clinical trial
Long-acting beta-adrenoceptor agonist

Click the tags to see associated articles and topics

View Article Details
TOP NEWS: AstraZeneca's Tezpire approved in EU for severe asthma - Shares Magazine

Added to Collection on: 2022-09-21 07:59:21

Tags for this article:

Health
Pharmaceutical industry
Respiratory therapy
Medical statistics
Asthma
Monoclonal antibodies
Clinical trial
AstraZeneca
Corticosteroid
Medication
Long-acting beta-adrenoceptor agonist

Click the tags to see associated articles and topics

View Article Details
Brookstone Capital Management Acquires 1542 Shares of Innoviva, Inc. (NASDAQ:INVA)

Added to Collection on: 2022-09-25 10:39:53

Tags for this article:

Financial markets
Drugs
Finance
Ellipta
Vilanterol
Equity securities
Stock market
Long-acting beta-adrenoceptor agonist
Umeclidinium bromide/vilanterol
Short
Stock
Innoviva Inc

Click the tags to see associated articles and topics

View Article Details
18864 Shares in Innoviva, Inc. (NASDAQ:INVA) Purchased by Meritage Portfolio Management

Added to Collection on: 2022-10-07 22:23:23

Tags for this article:

Financial markets
Finance
Financial economics
Stock market
Equity securities
Ellipta
Vilanterol
Short
Long-acting beta-adrenoceptor agonist
Stock
Innoviva Inc

Click the tags to see associated articles and topics

View Article Details
Innoviva Reports Third Quarter 2022 Financial Results and Highlights Recent Company Progress

Added to Collection on: 2022-11-10 06:14:31

Tags for this article:

Financial markets
Corporate finance
Companies
Ellipta
Profit
Vilanterol
Long-acting beta-adrenoceptor agonist
Beta2-adrenergic agonist
Fluticasone furoate
Forward-looking statement
Royalty payment
Net income
Innoviva Inc

Click the tags to see associated articles and topics

View Article Details
AstraZeneca and C4X Discovery Ink $402M COPD Collaboration | BioSpace

Added to Collection on: 2022-11-28 21:29:09

Tags for this article:

Medicine
Health
Clinical medicine
Respiratory therapy
Respimat
Chronic obstructive pulmonary disease
Obstructive lung disease
Long-acting beta-adrenoceptor agonist
Boehringer Ingelheim
AstraZeneca
Respiratory disease
Bronchodilator

Click the tags to see associated articles and topics

View Article Details
Innoviva (NASDAQ:INVA) Shares Gap Up to $15.28 - American Banking and Market News

Added to Collection on: 2024-03-03 21:58:47

Tags for this article:

Equity securities
Ellipta
Vilanterol
Fluticasone furoate/umeclidinium bromide/vilanterol
Long-acting beta-adrenoceptor agonist
NASDAQ
Hedge fund
Price?earnings ratio
Stock

Click the tags to see associated articles and topics

View Article Details
Sanofi's Dupixent Approved by EU as Targeted Therapy for Uncontrolled COPD

Added to Collection on: 2024-07-08 19:43:36

Tags for this article:

Chronic lower respiratory diseases
Dupilumab
Sanofi
Chronic obstructive pulmonary disease
Acute exacerbation of chronic obstructive pulmonary disease
Long-acting beta-adrenoceptor agonist
Fluticasone furoate/umeclidinium bromide/vilanterol
Draft:Anti-asthmatic agents

Click the tags to see associated articles and topics

View Article Details
Press Release: Dupixent approved in the US as the first-ever biologic medicine for patients ...

Added to Collection on: 2024-09-27 14:01:33

Tags for this article:

Chronic lower respiratory diseases
Chronic obstructive pulmonary disease
Dupilumab
Asthma
Bronchitis
Acute exacerbation of chronic obstructive pulmonary disease
Sanofi
Long-acting beta-adrenoceptor agonist
Regeneron Pharmaceuticals
u.s. food and drug administration
United States

Click the tags to see associated articles and topics

View Article Details
AstraZeneca asthma drug more effective during attack than steroids, study finds

Added to Collection on: 2024-11-28 11:30:59

Tags for this article:

Chronic lower respiratory diseases
Asthma
Respiratory therapy
Respiratory diseases
Antiasthmatic drugs
Chronic obstructive pulmonary disease
Acute exacerbation of chronic obstructive pulmonary disease
Corticosteroid
AstraZeneca
Benralizumab
Respiratory disease
Long-acting beta-adrenoceptor agonist

Click the tags to see associated articles and topics

View Article Details